Overall survival. by Shivani Patel (4742748)

“…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”

Progression-free survival by treatment. by Shivani Patel (4742748)

“…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”

Maintenance regimen and adverse event management. by Shivani Patel (4742748)

“…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”

BCC-specific survival. by Shivani Patel (4742748)

“…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”

Demographic data of the ED visits due hand injuries and subsequent hand operations, 2020 compared with mean of reference years 2017–2019. by Ilari Kuitunen (11084096)

Temporal distributions of inscriptions and occupations using uniform 50-years-long timeblocks. by Vojtěch Kaše (6156971)

Effect of dexmedetomidine (5 μg∙kg⁻¹ or 50 μg∙kg⁻¹) at experimental recording (Protocol 1). by Yoichiro Kitajima (4319455)

Subjects:

DAF-16/FOXO is Required for Locomotory Healthspan and Lifespan Benefits of Genetic Glycolysis Disruption. by Brian Onken (86790)

“…<i>daf-16</i> mutants are documented to have lowered locomotory ability vs. WT later in life [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008982#pgen.1008982.ref091" target="_blank">91</a>, <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008982#pgen.1008982.ref092" target="_blank">92</a>]; we note that, although comparison of scores across experiments is not possible due to variation in baseline values, the swimming rate of <i>daf-16(mgDf50)</i> control animals was slightly lower than WT controls on the same day of life (in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008982#pgen.1008982.g001" target="_blank">Fig 1C</a>; mean of 46.17 head thrashes/30 sec. for <i>daf-16</i> vs. 52.17 head thrashes/30 sec. for WT on day 10). …”

cIN accumulate in the ventrolateral cortex of <i>Emx1</i>-cKO mice. by Sathish Venkataramanappa (10331993)

Results of two-way repeated measure ANOVAs for various HRV indicators. by Duyan Geng (12072181)

Subjects:

Tension ratings at different period under taVNS or staVNS. by Duyan Geng (12072181)

Subjects:

Descriptive statistics of HRV indicators among the three recordings (baseline, stimulation, recovery) under taVNS or staVNS conditions. by Duyan Geng (12072181)

Subjects:

Descriptive statistics of Stimulation intensity, pain ratings and tension ratings under different stimulation conditions. by Duyan Geng (12072181)

Subjects:

Differences in stimulation intensity between various parameters. by Duyan Geng (12072181)

Subjects:

Procedure for study 1. by Duyan Geng (12072181)

Subjects:

Stimulation response by parameter over time. by Duyan Geng (12072181)

Subjects:

Procedure for study 2. by Duyan Geng (12072181)

Subjects:

Drugs IC₅₀s data during the study period. by Winnie Okore (14139712)

Summary of cell-based assay EC50 results for WT BMP9 and A347E variant. by Tobias G. Schips (21799838)

Barbie’s ankle equinus measured at 50 degrees as equnius posture (a) and flat foot posture measured at 0 degrees (b), with a handheld goniometer. by Cylie Williams (3446018)